Holen Sie sich die Stockscreener-App
12.37
0.00%
0.00
Handel nachbörslich:
12.48
0.11
+0.89%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$12.37
Offen:
$12.39
24-Stunden-Volumen:
3.24M
Relative Volume:
0.90
Marktkapitalisierung:
$2.47B
Einnahmen:
$3.90B
Nettoeinkommen (Verlust:
$-413.00M
KGV:
-5.9758
EPS:
-2.07
Netto-Cashflow:
$365.00M
1W Leistung:
+8.22%
1M Leistung:
+9.96%
6M Leistung:
-22.40%
1J Leistung:
-33.53%
1-Tages-Spanne:
$12.30
$12.53
1-Wochen-Bereich:
$11.23
$12.53
52-Wochen-Spanne:
$9.85
$20.59
Dentsply Sirona Inc Stock (XRAY) Company Profile
Firmenname
Dentsply Sirona Inc
Sektor
Telefon
844-546-3722
Adresse
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Vergleichen Sie XRAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
12.37 | 2.47B | 3.90B | -413.00M | 365.00M | -2.07 |
|
ISRG
Intuitive Surgical Inc
|
592.27 | 210.16B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
202.71 | 58.51B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
81.02 | 40.19B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
248.21 | 36.37B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
40.43 | 31.30B | 27.43B | 1.27B | 1.01B | 1.5829 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Underweight |
| 2025-11-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Herabstufung | Needham | Buy → Hold |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-23 | Herabstufung | Jefferies | Buy → Hold |
| 2025-01-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Bestätigt | Needham | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-16 | Eingeleitet | Needham | Buy |
| 2023-11-10 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Hochstufung | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-08-06 | Bestätigt | Barrington Research | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-02 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-01-05 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-12-18 | Herabstufung | Stifel | Buy → Hold |
| 2020-11-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-10-22 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-15 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-05-27 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-04-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Herabstufung | Goldman | Buy → Neutral |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-19 | Bestätigt | Stifel | Buy |
| 2019-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Hochstufung | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Eingeleitet | Evercore ISI | In-line |
| 2019-07-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten
AI-Based Caries Detection Presents a $1.11 Billion Global Market Opportunity by 2029 - GlobeNewswire Inc.
Analysts Are Bullish on These Healthcare Stocks: Fortrea Holdings Inc. (FTRE), DENTSPLY SIRONA (XRAY) - The Globe and Mail
Why Dentsply Sirona (XRAY) Stock Is Trading Up Today - Finviz
Bank of America Securities Reaffirms Their Hold Rating on DENTSPLY SIRONA (XRAY) - The Globe and Mail
Dentsply Sirona to Present at 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026 - Quiver Quantitative
Dentsply Sirona to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Dentsply Sirona Stock Up on Analyst RatingMarket Performance & Outlook | Jan 2026News and Statistics - IndexBox
The Truth About Dentsply Sirona Inc: Why Wall Street Is Watching While TikTok Sleeps On It - AD HOC NEWS
XRAY: Analyst Ratings and Target Price Unchanged by Barrington R - GuruFocus
DENTSPLY SIRONA's (XRAY) "Outperform" Rating Reiterated at Barrington Research - MarketBeat
Titanium & Titanium Alloys Dental Implants Market is expected - openPR.com
DENTSPLY SIRONA Inc Stock Analysis and ForecastEarnings Surprise Analysis & Build Your Portfolio With Our Free Stock Scanner - earlytimes.in
Dental Resin Market 2025-2032: Key Trends, Opportunities, - openPR.com
Dental Implants Market Booming with Rapid Growth Through 2032 | - openPR.com
Dental Digital X-ray Market Set to Transform Oral Care: - openPR.com
Dentsply Sirona Amends Credit Facilities to Enhance Flexibility - TipRanks
Dentsply Sirona amends credit agreements and updates debt covenants By Investing.com - Investing.com Nigeria
Dentsply Sirona amends credit agreements and updates debt covenants - Investing.com
Dentsply Sirona Updates Multiple Financing Agreements With Major Lenders - TradingView — Track All Markets
Why Is DENTSPLY SIRONA Inc. (DY2.DE) Stock Up Today? - Meyka
DENTSPLY SIRONA Inc. $XRAY Shares Purchased by Cwm LLC - MarketBeat
The Truth About Dentsply Sirona Inc: Is This ‘Boring’ Dental Stock a Secret Money Play? - AD HOC NEWS
Japan Dental Equipment Market is expected to reach US$ 9.20 - openPR.com
Dentsply Sirona stock holds $11.5 in early premarket as dividend date passes and earnings come into view - ts2.tech
Dentsply Sirona Earnings Notes - Trefis
Specialty Medical Chairs Market Analysis 2025 Review - openPR.com
Dentsply Sirona Stock (NASDAQ: XRAY) Update: Analysts’ “Reduce” Consensus, Dividend Timeline, and Key Catalysts Before Monday’s Open - ts2.tech
DENTSPLY SIRONA Stock (NASDAQ: XRAY) Weekend Update: Analysts Hold a “Reduce” View as Year-End Trading Winds Down - ts2.tech
Dentsply Sirona (XRAY) Stock Weekend Update: Dividend, Turnaround Plan, Analyst Targets—and What to Watch When Nasdaq Reopens - ts2.tech
Here’s What Weakened DENTSPLY SIRONA (XRAY) Shares - MSN
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Consensus Rating of "Reduce" from Analysts - MarketBeat
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Recommendation of "Reduce" from Brokerages - MarketBeat
DENTSPLY SIRONA Inc.: - marketscreener.com
Dental Equipment & Technology Stocks Q3 Results: Benchmarking Dentsply Sirona (NASDAQ:XRAY) - Yahoo Finance
Ex-Dividend Reminder: Medtronic, Danaher and DENTSPLY SIRONA - Nasdaq
Endodontics Market Size, Share & Forecast 2026–2035 - Global Market Insights Inc.
Bio-implant Market Projected to Witness Huge Growth - openPR.com
Sound Income Strategies LLC Boosts Stock Holdings in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Analysts Offer Insights on Healthcare Companies: Novavax (NVAX) and DENTSPLY SIRONA (XRAY) - The Globe and Mail
Dentsply Sirona declares $0.16 dividend - MSN
Why DENTSPLY SIRONA Inc. (DY2) stock signals breakout potentialWeekly Trend Recap & Daily Profit Maximizing Tips - Улправда
Lobbying Update: $50,000 of DENTSPLY SIRONA lobbying was just disclosed - Quiver Quantitative
Is DENTSPLY SIRONA Inc. (DY2) stock among top earnings playsMarket Trend Report & Stepwise Entry and Exit Trade Signals - DonanımHaber
How DENTSPLY SIRONA Inc. stock benefits from tech adoptionJuly 2025 Snapshot & AI Powered Market Entry Ideas - DonanımHaber
Squarepoint Ops LLC Cuts Position in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Has DENTSPLY SIRONA’s 39% Slide in 2025 Created a Value Opportunity? - Yahoo Finance
Assessing Dentsply Sirona (XRAY) Valuation After a Recent Share Price Rebound - Yahoo Finance
Dentsply International (XRAY) Surpasses Q1 Earnings and Revenue Estimates - sharewise.com
Barrington Research Maintains DENTSPLY SIRONA (XRAY) Outperform Recommendation - Nasdaq
DENTSPLY SIRONA (NASDAQ:XRAY) Receives "Outperform" Rating from Barrington Research - MarketBeat
Dentsply Sirona (XRAY) Maintains Outperform Rating with $14 Pric - GuruFocus
Finanzdaten der Dentsply Sirona Inc-Aktie (XRAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
1.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):